Rheumatic diseases affect women three times more often than men and innovative Stanford research points to gender-specific genetic switches playing a role in this disparate prevalence. A new technology for studying the body’s system for switching genes on and off reveals that genes associated with the immune system switch on and off more frequently, and these genes… Read more »
Our Community Blog features new studies, research highlights, updates on remission stories and other interesting snippets. Please note that opinions shared in Blog posts do not necessarily reflect those of The Foundation.
Rheumatic patients often find inflammation decreases after eliminating gluten. The existence of gluten sensitivity has been debated for many years due to the lack of a definitive testing method for a non-celiac form. However, more clarity on this issue could arise as the result of a presentation at the 23rd United European Gastroenterology Week in Barcelona, Spain, given by a research team… Read more »
Psittacosis, a rare form of chlamydial infection, was found to be the trigger for one woman’s debilitating arthritis. Very occasionally, a rheumatic patient will contact Road Back Foundation (RBF) with a curious story to tell. Alma had suffered with arthritic pain from the age of sixteen and was later diagnosed with seropositive rheumatoid arthritis on the basis of her clinical presentation that included an elevated rheumatoid factor. Her… Read more »
Reports that the cost of sixty capsules of Minocin, the original brand of minocycline, has risen to $3000 in the United States has been cause for serious concern for rheumatic patients who depend on this medication as a core therapy. Minocin is a second generation tetracycline that was synthesized in 1967 by Lederle Laboratories, was FDA approved in 1971, and… Read more »
Adding to the growing body of scientific evidence pointing to bacteria as a causative agent of rheumatic diseases, a ground-breaking study, led by researchers at Temple University School of Medicine (TUSM), in Philadelphia, was published in the journal, Immunity, on June 16th, 2015. By using mice that are genetically-prone to lupus, the Temple researchers were able to provoke the… Read more »
When you’ve just received a life-altering diagnosis, it’s common to be shocked and dismayed at the array of powerful drugs that may have been presented as the only options for treatment. If you’ve been unwell for some time, it’s possible that you’ve exhausted a number of drug options, because they no longer work or they… Read more »
Hello and welcome to our new website and Community Blog! It’s been a long time coming! But we are confident this is the beginning of a dynamic new online resource that will serve the needs of rheumatic patients and their advocates in the 21st Century. Our former website and forum were on an ancient platform… Read more »